# Five high-impact anesthesiology ideas (PhysioNet, full-access)

Synthesized from a database catalog (PHYSIONET_ANESTHESIA_DBS.md), a PubMed gap survey
(ANESTHESIA_RESEARCH_GAPS.md), and a waveform-construct brainstorm (INTRAOP_WAVEFORM_CONSTRUCTS.md).
Discipline applied (from the vasopressor post-mortem): avoid dose→outcome (VIS trap), avoid already-named
indices (HPI/SVV/PVI/ANI/NOL/BIS-titration), avoid confounded treatment-decision questions, and prefer
constructs with a clean external-validation path (VitalDB ↔ INSPIRE ↔ MOVER).

**Key assets:** VitalDB (open; 6,388 surgeries; 62.5–500 Hz ABP/ECG/PPG/capnography **+ BIS/EEG + NIRS
cerebral oximetry**; AKI/LOS/mortality) — the crown jewel. MOVER (83k surgeries, waveform+EHR, DUA).
INSPIRE (130k perioperative, deep outcomes, no waveforms — the external-validation registry).

---

## Idea 1 (TOP) — A frozen EEG foundation model on intraoperative EEG to predict postoperative outcomes
**Question:** Does a *pretrained, self-supervised* EEG foundation model (LaBraM/CBraMod/EEGPT — and this
repo's MORGOTH pipeline) applied to **raw intraoperative EEG** predict postoperative **delirium, AKI, and
mortality** — and beat both processed indices (BIS/PSI) and bespoke supervised models?
- **Why high-impact + novel:** EEG foundation models have **never** been applied to perioperative EEG for
  any postop outcome (verified). The nearest work, **DELPHI-EEG** (Ahn et al., *npj Digital Medicine* 2025,
  n=34,550, AUROC 0.87 for delirium), is a *bespoke supervised CNN-GCN-transformer trained from scratch on
  one dataset*, POD-only, no AKI/mortality, **no external validation**. Meanwhile EEG-guided *titration* is
  settled-null (ENGAGES/ENGAGES-Canada/Zhou 2025) — so the live question is *prediction/biomarker*, not
  titration, and raw/qEEG features already beat BIS/PSI in single cohorts (Zhao 2025, Guo 2024 AUC 0.81).
- **The differentiator:** a *frozen foundation model + linear probe* generalizes across outcomes and
  cohorts with little labeled data, and enables **cross-dataset external validation** (train-probe on
  VitalDB BIS/EEG → validate on MOVER / an external EEG cohort) — exactly the gap DELPHI left open.
- **Data:** VitalDB (BIS + raw EEG channels where present) for discovery; MOVER for external waveform
  replication; this repo already operationalizes a frozen clinical-EEG foundation model (CBraMod, sha-pinned).
- **Biggest threat:** raw intraop EEG availability/quality in VitalDB (many cases have processed BIS, fewer
  have raw multichannel EEG) — must quantify the usable-EEG cohort first. Frame against DELPHI-EEG as the
  named comparator. **Tier: Anesthesiology / npj Digital Medicine / JAMA-family.** Directly reuses the repo.

## Idea 2 — Wave-reflection RECOVERY KINETICS as a vasoregulatory-reserve marker → postop AKI / myocardial injury
**Question:** After a discrete intraoperative hemodynamic perturbation (induction, pneumoperitoneum,
cross-clamp/declamp, vasopressor bolus), how fast does the **reflected-wave / augmentation-index trajectory
recover** (its half-life), and does slow recovery — a depleted vasoregulatory reserve — predict postop AKI
and myocardial injury, *independent of absolute MAP exposure*?
- **Why novel:** the object is the **recovery time-course of wave reflection**, not the static augmentation
  index (a named quantity). Only close prior art is one narrow liver-transplant study on binary reflected-wave
  presence — no generalizable recovery-kinetics construct exists. It is invisible to TWA-MAP / AUC-MAP<65,
  the entire current intraop-hypotension literature — a genuinely new mechanism in the field's hottest topic.
- **Data:** VitalDB arterial waveform (universally available); validate the AKI signal in INSPIRE's organ
  outcomes (using its summary hemodynamics as a coarse check).
- **Biggest threat:** wave separation classically needs an aortic-flow estimate; pressure-only surrogates
  (reservoir-wave / triangular flow) must be validated. **Tier: Anesthesiology / BJA.**

## Idea 3 — The individual "cerebral pressure/dose-passivity point": personalized EEG-suppression threshold → delirium
**Question:** For each patient, find the **MAP (and anesthetic-dose/MAC) at which their cortical EEG collapses
toward burst suppression** — a *personalized cerebral-susceptibility threshold* — and test whether a higher
(more fragile) threshold predicts postoperative delirium, reframing burst suppression from an *event count*
to an *individual vulnerability phenotype*.
- **Why novel + timely:** burst-suppression→delirium is association-only and avoidance trials are null
  (ENGAGES, AlphaMax) → the field now believes it's a **vulnerable-brain marker, not a modifiable cause**
  (frailty predicts it; desflurane dissociates it). No one has operationalized the *individual threshold*
  (the dose/pressure at which suppression onsets) as a precision biomarker. Aligns with the 2026 "precision
  perioperative brain health" editorial push.
- **Data:** VitalDB (BIS + ABP + anesthetic concentration, time-aligned). Differentiate carefully from
  COx/BISopt autoregulation methods (which need NIRS).
- **Biggest threat:** anesthetic depth (MAC) confounds suppression — must rigorously separate the
  *pressure*-passivity from the *dose*-passivity component. **Tier: Anesthesiology / BJA.**

## Idea 4 — Continuous intraoperative ventilator-waveform DYNAMICS → postoperative pulmonary complications
**Question:** Do **trajectory/dynamic signatures** of intraoperative ventilator mechanics (beat-by-breath
driving-pressure variability, compliance drift, recruitment-derecruitment hysteresis) predict postoperative
pulmonary complications **beyond single-timepoint driving pressure / PEEP** — the targets that just FAILED on
hard outcomes in the 29-site JAMA 2026 RCT?
- **Why high-impact + open:** individualized-PEEP / driving-pressure trials are contested and the **largest,
  newest RCT (JAMA 2026, n=1,435) is null on PPCs** while increasing hypotension — the field needs a better
  ventilation target. Essentially all prior work uses *single-timepoint* mechanics; **continuous
  waveform-to-outcome modeling is an explicitly nascent gap** (only a 2025 methods preprint). A dynamic
  signature that outpredicts static driving pressure would reframe the target.
- **Data:** VitalDB ventilator waveforms (pressure/flow/volume) + PPC-relevant outcomes; MOVER for the large-N
  external check (11 postop complication categories).
- **Biggest threat:** confounding by surgery type/duration and ventilator-mode heterogeneity; PPC outcome
  definition. **Tier: Anesthesiology / BJA / AJRCCM.**

## Idea 5 — A retrospective MULTIMODAL nociception signature (EEG + HRV + arterial/PPG) → postop pain & opioid need
**Question:** Does an integrated **multimodal** intraoperative signature (processed-EEG + heart-rate
variability + arterial/PPG morphology) predict postoperative pain trajectory and opioid requirement better
than any single commercialized nociception index (ANI/NOL/SPI), using the raw co-recorded waveforms?
- **Why timely:** the 2024 BJA network meta-analysis found *only pupillometry* sparing opioids and all
  single-modality monitors "limited clinical benefit"; the 2025–26 literature (Vide 2025; Mogianos 2026)
  **explicitly calls for multimodal EEG+autonomic+hemodynamic integration** — but it has not been built on a
  large retrospective waveform dataset. Novelty rests on the *specific multimodal implementation*, not the
  idea (which is now in print), so it must be executed and externally validated to land.
- **Data:** VitalDB (BIS/EEG + ECG→HRV + ABP/PPG, all co-recorded). Outcome granularity (postop pain scores)
  in VitalDB must be checked first — this is the main feasibility risk.
- **Biggest threat:** coarse/again-confounded pain outcomes; the concept is already called-for (lower
  novelty ceiling than 1–3). **Tier: A&A / BJA.**

---

## Ranking & recommendation
1. **Idea 1 (EEG foundation model → postop outcomes)** — highest impact, genuinely unexplored, *and reuses
   this repo's existing frozen-EEG-foundation-model infrastructure*; clean external-validation story. Top pick.
2. **Idea 2 (wave-reflection recovery kinetics)** — most original *physiological* construct; new mechanism in
   the field's hottest topic (intraop hypotension/organ injury); ABP-only = maximally feasible on VitalDB.
3. **Idea 3 (individual cerebral-susceptibility threshold)** — novel precision-biomarker reframe of a live debate.
4. **Idea 4 (ventilator-waveform dynamics)** — rides a high-stakes, freshly-contested question (JAMA 2026 null).
5. **Idea 5 (multimodal nociception)** — strong tailwind but lower novelty ceiling (concept already in print).

First feasibility gate for whichever is chosen: confirm the *usable signal cohort* in VitalDB (raw EEG for #1;
clean ABP-perturbation episodes for #2; BIS+MAC for #3; ventilator waveforms for #4; co-recorded EEG+ECG+PPG
for #5) before committing — the discipline that (correctly) bounded the prior pivots early.

Cross-ref: PHYSIONET_ANESTHESIA_DBS.md, ANESTHESIA_RESEARCH_GAPS.md, INTRAOP_WAVEFORM_CONSTRUCTS.md.
